Hypertension, Hydrogen Peroxide and Vascular Inflammation
Hypertension, Hydrogen Peroxide and Vascular Inflammation
批准号:
7899832
负责人:
William Robert Taylor
金额:
$34.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-04 至 2012-06-30
关键词:
AdhesionsApolipoprotein EAtherosclerosisBlood VesselsCell ProliferationCellsComplexDataDevelopmentDiseaseElementsEndothelial CellsEndotheliumEventGene ExpressionGenetic ModelsHealthHeart failureHydrogen PeroxideHypertensionHypertrophyIn VitroInflammationInflammatoryInflammatory ResponseKidney FailureLaboratoriesLeadMechanicsMediator of activation proteinMolecularMusOrganPathogenesisPathologyPlayPositioning AttributeProductionReactive Oxygen SpeciesRelative (related person)RoleSeriesSignal TransductionSmooth MuscleSmooth Muscle MyocytesSourceStimulusStrokeTestingTherapeuticTissuesTransgenic MiceUnited StatesVascular Smooth Musclecatalasecell motilitycell typecomparativehypertension treatmentin vivointerestmacrophagemonocytenoveloverexpressionpublic health relevanceresponsevascular inflammation
中文摘要
描述(由申请人提供):高血压向动脉壁传递一系列复杂的体液和机械信号,导致炎症状态的发展。最近的研究表明,活性氧的产生是高血压血管病理学发病机制的核心。在本申请中,我们提出测试的假设,即在设置的高血压,局部生产过氧化氢的血管平滑肌细胞,内皮细胞和/或驻地巨噬细胞是一个关键的信号事件中发生的炎症反应,在高血压动脉壁。为了实现这一总体目标,我们已经开发了一种新的转基因小鼠,将允许组织特异性过氧化氢酶的过度表达。通过这些研究,我们将能够在细胞水平上修改局部H2 O2的产生,并确定随后对活性氧的产生,炎症基因表达和高血压诱导的动脉粥样硬化的发展的影响。建议的具体目标是:I:确定平滑肌特异性过氧化氢酶过表达对高血压诱导的炎症和动脉粥样硬化发展的影响。II:检查巨噬细胞特异性过氧化氢酶过表达对高血压血管后果的比较作用。第三章:探讨过氧化氢酶内皮特异性过表达对血管功能、炎症和高血压诱导的动脉粥样硬化进展的潜在作用。公共卫生相关性:高血压是当今美国的主要健康问题。高血压的病理后果是无数的,包括动脉粥样硬化、中风、心力衰竭、肾衰竭和其他终末器官疾病。本申请中的拟议研究将调查局部H2 O2产生在血管炎症反应中的潜在作用,以确定H2 O2在高血压血管疾病发病机制中的因果作用。
英文摘要
DESCRIPTION (provided by applicant): Hypertension imparts a series of complex humoral and mechanical signals to the arterial wall that result in the development of an inflammatory state. Recent studies have implicated the production of reactive oxygen species as central to the pathogenesis of hypertensive vascular pathology. In this application, we propose to test the hypothesis that in the setting of hypertension, local production of hydrogen peroxide by vascular smooth muscle cells, endothelial cells and/or resident macrophages is a pivotal signaling event in the inflammatory responses that occur in the hypertensive arterial wall. To accomplish this overall objective we have developed a novel transgenic mouse that will allow tissue-specific overexpression of catalase. Through these studies we will be able to modify local H2O2 production at the cellular level and determine the subsequent effects on production of reactive oxygen species, inflammatory gene expression and the development of hypertension-induced atherosclerosis. The proposed specific aims are: I: To determine the effects of smooth muscle-specific overexpression of catalase on the development of hypertension-induced inflammation and atherosclerosis. II: Examine the comparative effects of macrophage-specific overexpression of catalase on the vascular consequences of hypertension. III: To determine the potential functional contributions endothelial-specific overexpression of catalase on vascular function, inflammation and the progression of hypertension-induced atherosclerosis. PUBLIC HEALTH RELEVANCE: Hypertension is a major health problem in the United States today. The pathological consequences of hypertension are myriad and include atherosclerosis, stroke, heart failure, kidney failure and other end organ disease. The proposed studies in this application will investigate the potential role of localized H2O2 production in vascular inflammatory responses in an effort to define the causal role of H2O2 in the pathogenesis of hypertensive vascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER
-
批准号:8167000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:William Robert Taylor
-
依托单位:
Biology, Biomechanics and Atherosclerosis
-
批准号:7822529
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7731048
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9271227
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:8935386
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8088112
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7915248
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9100846
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8296360
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Role of inflammatory cell RAGE in collateral vessel formation
-
批准号:7788446
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7952042
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:7682311
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:8116635
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7716577
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7607806
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
MALT LIQUOR
-
批准号:7607808
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
Vascular specific ACE expression and atherosclerosis
-
批准号:7409084
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7606883
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7378661
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
MALT LIQUOR
-
批准号:7378687
-
项目类别:
-
资助金额:$0.93万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
海外基金